Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management

Sepsis remains a leading global cause of mortality, with delayed recognition and empirical antibiotic overuse fueling poor outcomes and rising antimicrobial resistance. This systematic scoping review evaluates the current landscape of artificial intelligence (AI) and machine learning (ML) applicatio...

Full description

Saved in:
Bibliographic Details
Main Authors: Georgios I. Barkas, Ilias E. Dimeas, Ourania S. Kotsiou
Format: Article
Language:English
Published: MDPI AG 2025-07-01
Series:Diagnostics
Subjects:
Online Access:https://www.mdpi.com/2075-4418/15/15/1890
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849406254754037760
author Georgios I. Barkas
Ilias E. Dimeas
Ourania S. Kotsiou
author_facet Georgios I. Barkas
Ilias E. Dimeas
Ourania S. Kotsiou
author_sort Georgios I. Barkas
collection DOAJ
description Sepsis remains a leading global cause of mortality, with delayed recognition and empirical antibiotic overuse fueling poor outcomes and rising antimicrobial resistance. This systematic scoping review evaluates the current landscape of artificial intelligence (AI) and machine learning (ML) applications in sepsis care, focusing on early detection, personalized antibiotic management, and resistance forecasting. Literature from 2019 to 2025 was systematically reviewed following PRISMA-ScR guidelines. A total of 129 full-text articles were analyzed, with study quality assessed via the JBI and QUADAS-2 tools. AI-based models demonstrated robust predictive performance for early sepsis detection (AUROC 0.68–0.99), antibiotic stewardship, and resistance prediction. Notable tools, such as InSight and KI.SEP, leveraged multimodal clinical and biomarker data to provide actionable, real-time support and facilitate timely interventions. AI-driven platforms showed potential to reduce inappropriate antibiotic use and nephrotoxicity while optimizing outcomes. However, most models are limited by single-center data, variable interpretability, and insufficient real-world validation. Key challenges remain regarding data integration, algorithmic bias, and ethical implementation. Future research should prioritize multicenter validation, seamless integration with clinical workflows, and robust ethical frameworks to ensure safe, equitable, and effective adoption. AI and ML hold significant promise to transform sepsis management, but their clinical impact depends on transparent, validated, and user-centered deployment.
format Article
id doaj-art-9b16e0a9a09f4174826d78bfce81cf5c
institution Kabale University
issn 2075-4418
language English
publishDate 2025-07-01
publisher MDPI AG
record_format Article
series Diagnostics
spelling doaj-art-9b16e0a9a09f4174826d78bfce81cf5c2025-08-20T03:36:26ZengMDPI AGDiagnostics2075-44182025-07-011515189010.3390/diagnostics15151890Bug Wars: Artificial Intelligence Strikes Back in Sepsis ManagementGeorgios I. Barkas0Ilias E. Dimeas1Ourania S. Kotsiou2Laboratory of Human Pathophysiology, Department of Nursing, School of Health Sciences, University of Thessaly, 41500 Larissa, GreeceDepartment of Respiratory Medicine, Faculty of Medicine, School of Health Sciences, University of Thessaly, 41110 Larissa, GreeceLaboratory of Human Pathophysiology, Department of Nursing, School of Health Sciences, University of Thessaly, 41500 Larissa, GreeceSepsis remains a leading global cause of mortality, with delayed recognition and empirical antibiotic overuse fueling poor outcomes and rising antimicrobial resistance. This systematic scoping review evaluates the current landscape of artificial intelligence (AI) and machine learning (ML) applications in sepsis care, focusing on early detection, personalized antibiotic management, and resistance forecasting. Literature from 2019 to 2025 was systematically reviewed following PRISMA-ScR guidelines. A total of 129 full-text articles were analyzed, with study quality assessed via the JBI and QUADAS-2 tools. AI-based models demonstrated robust predictive performance for early sepsis detection (AUROC 0.68–0.99), antibiotic stewardship, and resistance prediction. Notable tools, such as InSight and KI.SEP, leveraged multimodal clinical and biomarker data to provide actionable, real-time support and facilitate timely interventions. AI-driven platforms showed potential to reduce inappropriate antibiotic use and nephrotoxicity while optimizing outcomes. However, most models are limited by single-center data, variable interpretability, and insufficient real-world validation. Key challenges remain regarding data integration, algorithmic bias, and ethical implementation. Future research should prioritize multicenter validation, seamless integration with clinical workflows, and robust ethical frameworks to ensure safe, equitable, and effective adoption. AI and ML hold significant promise to transform sepsis management, but their clinical impact depends on transparent, validated, and user-centered deployment.https://www.mdpi.com/2075-4418/15/15/1890artificial intelligencemachine learningpredictionsepsis
spellingShingle Georgios I. Barkas
Ilias E. Dimeas
Ourania S. Kotsiou
Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management
Diagnostics
artificial intelligence
machine learning
prediction
sepsis
title Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management
title_full Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management
title_fullStr Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management
title_full_unstemmed Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management
title_short Bug Wars: Artificial Intelligence Strikes Back in Sepsis Management
title_sort bug wars artificial intelligence strikes back in sepsis management
topic artificial intelligence
machine learning
prediction
sepsis
url https://www.mdpi.com/2075-4418/15/15/1890
work_keys_str_mv AT georgiosibarkas bugwarsartificialintelligencestrikesbackinsepsismanagement
AT iliasedimeas bugwarsartificialintelligencestrikesbackinsepsismanagement
AT ouraniaskotsiou bugwarsartificialintelligencestrikesbackinsepsismanagement